NNelo Trade
Trading Workspace
← Back to Market News
November 05, 2026 at 09:03 PM UTC

8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer)

Filed: 2026-11-05 AccNo: 0001628280-26-070987 Size: 159 KB Item 1.02: Termination of a Material Definitive Agreement Item 2.05: Cost Associated with Exit or Disposal Activities Item 9.01: Financial Statements and Exhibits

Official source: U.S. Securities and Exchange Commission

Official source published: November 05, 2026 at 09:01 PM UTC

Open official source
8-K - Acumen Pharmaceuticals, Inc. (0001576885) (Filer) | Nelo Trade